2.44
-0.045(-1.81%)
Currency In USD
| Previous Close | 2.49 |
| Open | 2.44 |
| Day High | 2.51 |
| Day Low | 2.42 |
| 52-Week High | 4.74 |
| 52-Week Low | 0.95 |
| Volume | 53,856 |
| Average Volume | 4.7M |
| Market Cap | 42.14M |
| PE | -0.32 |
| EPS | -7.67 |
| Moving Average 50 Days | 2.57 |
| Moving Average 200 Days | 3.15 |
| Change | -0.05 |
If you invested $1000 in Mural Oncology plc (MURA) since IPO date, it would be worth $642.11 as of July 12, 2025 at a share price of $2.44. Whereas If you bought $1000 worth of Mural Oncology plc (MURA) shares 1 year ago, it would be worth $746.18 as of July 12, 2025 at a share price of $2.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Mural Oncology Announces Number of Relevant Securities in Issue
GlobeNewswire Inc.
May 19, 2025 7:57 PM GMT
WALTHAM, Mass. and DUBLIN, May 19, 2025 (GLOBE NEWSWIRE) -- In accordance with Rule 2.12 of the Irish Takeover Panel Act 1997, the Irish Takeover Rules 2022 (the “Irish Takeover Rules”), Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-on
FORM 8.1(a) & (b) - Mural Oncology plc
GlobeNewswire Inc.
Apr 30, 2025 7:07 PM GMT
Ap9 FORM 8.1(a) & (b)(Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1. KEY INFORMATION (a) Full n
Mural Oncology Announces Plans to Explore Strategic Alternatives
GlobeNewswire Inc.
Apr 15, 2025 12:00 PM GMT
Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will discontinue all clinical development of nemvaleukin With $144.4 million in cash as of December 31, 2024, Mural p